The Forum > Article Comments > The Gardasil 'miracle' coming undone? > Comments
The Gardasil 'miracle' coming undone? : Comments
By Renate Klein, published 21/8/2008Action is needed before the luck runs out: the Gardasil vaccination program should be suspended now.
- Pages:
-
- 1
- 2
- 3
- Page 4
-
- All
Business management,spurred on by avaricious stake/share holders are more concerned about dividends, EPS's, and double digit Superannuation Fund returns than legions of dying and infected F&M with incurable diseases.
Least of their worries. The circus band plays on.
Merck Sharp& Dohme's world wide sales (2008) $24.4B. Up 10%.Commonwealth Serum Laboratories, established 1916, represented 27 Countries (2008) revenue $ 702. Up 30%. ASX shares currently $ 37.67.
Scenario: Bull. Buy.
If you want solid growth, security and uninterrupted sleep at night, this is the place to be.
History records Health Minister in the Howard Govt, Tony Abbot who approved PBS listing of Gardasil through the Medical Assn Committee, TGA and Drug Evaluation Commission 2006. For 3 shots @ $135.00. Pharmacy's dispensing fee's 3 @ $12.50, plus Doctor's visit 3@ $85.00
Spin off's include courier service,syringe disposal,refrigeration, post-trauma backup, research grants, subsidies, clinical trials, drug monitoring, red tape etc. One soon get the hang of the cost involved and corpulent taxpayer's largesse. To date 26 million doses World-wide with 3.7 Aussie females aged 11-26.
Merck in it's relentless drive for market share have been cited by FDA for false advertising, and arguably miraculous claims of cancer cures from their product. Merck Aust registered Gardasil June 2006. Resolution 8971 " a prophylactic HPV vaccine for types 6,11,16,18. GlaxoSmith: Cervarix for type 16, 18.
Interesting enough of 130 strains of Human Papillomana Virus (HPV)only 3 % are identifiable types. Verrucae (warts)Cervical Cancer. Cancer with no symptoms. Dispute surfaces when exorbitant blanket claims of 70-80 % covers all cerv cancers when in fact only 2 strains, and anal cancer 6,11 is addressed. At present there is no FDA approved screening test for verrucae. What of the remaining 97 %.Moreover, Pap smear screening only identifies visual abnormalities !
US Cancer Assn estimates (08)of 11,070 females diagnosed with invasive cerv cancer, 3870 will die.By year 2010,